Graham Packham, PhD
Professor of Molecular Oncology, University of Southampton, Southampton, UK
Email: G.K.Packham@soton.ac.uk
Nicola Normanno, MD
Chief of Cell Biology and Biotherapy Unit, Director of Translational Research Department, Istituto Nazionale Tumori "Fondazione Pascale" Via Mariano Semmola, Naples, Italy
Email: nicnorm@yahoo.com
Giuseppe Curigliano, MD, PhD
Interests: breast cancerl; early drug development; precision oncology; biomarkers; NGS
Associate Professor of Medical Oncology, University of Milan; Head, Division of Early Drug Development, European Institute of Oncology, Milan, Italy
Gennaro Daniele, MD, PhD
Interests: drug development; clinical trials; translational research; gynecologic malignancies; biomarkers
Scientific Director, Clinical Trials Center, Agostino Gemelli University Policlinic, Rome, Italy
Jianxun Ding, PhD
Interests: polymer chemistry; biomaterial; controlled drug delivery; immunotherapy; regenerative medicine
Associate Professor, Key Laboratory of Polymer Ecomaterials, Changchun Institute of Applied Chemistry, Chinese Academy of Sciences, China
Alan L. Epstein, MD, PhD
Interests: cancer immunotherapy; antibody targeting; tumor antigens; CAR T-cell therapy; tumor models
Professor of Pathology, Department of Pathology, University of Southern California, Los Angeles, USA
A. Ganesan, PhD
Interests: medicinal chemistry; chemical biology; organic synthesis; epigenetics; natural products
Professor in Chemical Biology, School of Pharmacy, University of East Anglia, Norwich, UK
Marius Ilie, MD, PhD
Interests: pathology; lung cancer; biomarkers; liquid biopsy; precision pathology
Professor of Pathology, Université Côte d'Azur; Surgical Pathologist, Nice University Hospital, Nice, France
Nagesh Kalakonda, PhD
Interests: B-cell malignancies; clinical trials; drug therapy and signalling
Reader and Honorary Consultant, Department of Molecular and Clinical Cancer Medicine, University of Liverpool, Liverpool, UK
Simon Langdon, MA, PhD
Interests: ovarian cancer; breast cancer; estrogen signaling; HER signaling; DNA repair
Reader, School of Medicine, University of Edinburgh, Edinburgh, UK
Wan-Liang Lu, PhD
Interests: resistant cancer; cancer stem cells; gene regulation; nanomaterials; liposomes
Professor and Vice Dean, School of Pharmaceutical Sciences, Peking University, China
Erika Martinelli, MD, PhD
Interests: colorectal cancer; translational research; resistance to targeted therapies; gastrointestinal cancer
Associate Professor in Medical Oncology, Department of Precision Medicine, Università degli Studi della Campania L. Vanvitelli, Naples, Italy
Alessandro Morabito, MD
Interests: lung cancer; target based agents; angiogenesis inhibitors; immunotherapy; clinical trials
Director of Thoracic Medical Oncology, Istituto Nazionale Tumori "Fondazione Pascale" Via Mariano Semmola, Naples, Italy
David Rizzieri, MD
Interests: stem cell transplant; cellular therapy and CAR-T; leukemia; lymphoma; clinical trials
Professor of Medicine, Duke University Medical Center; Chief, Section of Hematologic Malignancies, Duke Cancer Institute, Durham, USA
Gautam Sethi, PhD
Interests: signal transduction; apoptosis; transcription factors; metastasis; mouse models of cancer
Associate Professor, Department of Pharmacology, Yong Loo Lin School of Medicine, National University of Singapore, Singapore
Valerie Speirs, PhD
Interests: oestrogen receptor biology; endocrine resistant breast cancer; male breast cancer; in vitro models; biomarker
Professor and Chair in Molecular Oncology, Institute of Medical Sciences, University of Aberdeen, Aberdeen, UK
Luca Agnelli, PhD
Interests: lymphoid malignancies; bioinformatics and biostatistics in cancer; -omics analyses; NGS; non-coding RNA
Post-doc, Department of Oncology and Hemato-oncology, University of Milan, Milan, Italy
Rossana Berardi, MD
Professor in Medical Oncology at Università Politecnica Marche; Director of Department of Medical Oncology, Director of the Postgraduate School of Oncology, Head of “Genetic Cancer” Laboratory, Deputy Director of Department of Clinical and Molecular Science, at Università Politecnica Marche, Ancona, Italy.
Laura Cerchia, PhD
Interests: aptamers; cell-SELEX; cancer theranostics; cell-surface receptors; tumor‐targeted drug delivery
Research Scientist, Group Leader, Institute of Experimental Endocrinology and Oncology "G. Salvatore" (IEOS), National Research Council (CNR), Naples, Italy
Eyad Elkord, PhD
Interests: tumor immunology; cancer immunotherapy; immunosuppression; T regulatory cells; cancer epigenetics
Principal Investigator and Professor, Qatar Biomedical Research Institute, Hamad Bin Khalifa University, Qatar; Honorary Professor, University of Manchester, UK
Vanesa Gregorc, MD
Interests: thoracic neoplasm; lung cancer; pleural mesothelioma; thymus cancer; immuno-oncology
Thoracic Oncology, Head and Neck and Melanoma Area Coordinator, IRCSS Scientific Institute, University Hospital San Raffaele, Milan, Italy
Valentina Guarneri, MD
Interests: breast cancer; acute myeloid leukemia; HER2-posite breast cancer; videos breast cancer
Associate Professor of Oncology, University of Padua, Padua, Italy
Sudeep Gupta, MD
Interests: breast cancer; gynecological cancer; clinical trials
Professor of Medical Oncology, Director, Advanced Centre for Treatment Research and Education in Cancer (ACTREC), Tata Memorial Centre, Mumbai, India
Weilin Jin, MD, PhD
Interests: brain tumors; cancer stem cells; epigenetics in cancer biology; cancer immunotherapy
Associated Professor, School of Science and Techology, Shanghai Jiao Tong University, Shanghai, China
Richard Kornbluth, MD, PhD
Interests: dendritic cells; TNF superfamily ligands; CD40 ligand; 4-1BB ligand; latent membrane protein-1 (LMP1)
Professor, Vaccine Research Institute of San Diego; CEO, Multimeric Biotherapeutics, Inc., San Diego, USA
Ajaikumar Kunnumakkara, PhD
Interests: cancer; inflammation; drug discovery; targeted delivery of drugs; discovery of novel targets
Professor, Department of Biosciences and Bioengineering, Indian Institute of Technology Guwahati, Assam, India
